Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19 | $24 | $31 | $9 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $1 | $4 | $2 |
| Inventory | $0 | $1 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $1 | $1 |
| Total Curr. Assets | $21 | $27 | $36 | $12 |
| Property Plant & Equip (Net) | $2 | $3 | $7 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15 | $15 | $15 | $15 |
| Long-Term Investments | $0 | $2 | $2 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $5 | $1 | $4 |
| Total NC Assets | $23 | $24 | $24 | $23 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $44 | $51 | $60 | $35 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $2 |
| Short-Term Debt | $2 | $2 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $4 | $6 | $4 |
| Total Curr. Liab. | $8 | $7 | $10 | $7 |
| LT Debt | $2 | $2 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $44 | $41 | $38 | $38 |
| Total NC Liab. | $45 | $43 | $40 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $3 | $3 | $4 |
| Total Liabilities | $53 | $49 | $50 | $47 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $369 | $368 | $367 | $338 |
| Retained Earnings | -$378 | -$367 | -$357 | -$351 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$9 | $1 | $10 | -$12 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $44 | $51 | $60 | $35 |
| Net Debt | -$16 | -$21 | -$28 | -$5 |